Weight-loss drug reduces risk of early death for patients with heart failure, trial finds
Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function, new research reveals.
20 Nov 00:00 · ScienceDaily
Titrzepatide reduces risk of death or worsening heart failure for patients with obesity-related heart failure
Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and obesity, new research from UVA Health reveals.
21 Nov 05:37 · News-Medical
last updated on 21 Nov 20:59